Instability of lopinavir/ritonavir capsules at ambient temperatures in sub-Saharan Africa: Relevance to WHO antiretroviral guidelines

AIDS

Volumn 19, Issue 11, 2005, Pages 1233-1234

  Pau, Alice K ^a   Moodley, Neelambal K ^b   Holland, Diane T ^c   Fomundam, Henry ^e   Matchaba, Gugu U ^f   Capparelli, Edmund V ^c,d  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b South African Military Health System   (South Africa)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^f Project Phidisa   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

LOPINAVIR PLUS RITONAVIR;

AFRICA; ARTICLE; DRUG FORMULATION; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; ENVIRONMENTAL TEMPERATURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

EID: 23044485111     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000176227.01850.9e     Document Type: Article

References (2)

1. World Health Organization. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. Geneva: World Health Organization; December 2003.
2. Kaletra® product labeling. North Chicago, IL, USA: Abbott Laboratories; 2004.